Abdominal obesity is associated with increased risk of acute coronary events in men.

PubWeight™: 2.46‹?› | Rank: Top 2%

🔗 View Article (PMID 11977996)

Published in Eur Heart J on May 01, 2002

Authors

H-M Lakka1, T A Lakka, J Tuomilehto, J T Salonen

Author Affiliations

1: Department of Public Health and General practice, Research Institute of Public Health, University of Kuopio, Kuopio, Finland.

Associated clinical trials:

Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio) | NCT00005260

Rehabilitation of Type 2 Diabetes Patients. | NCT00284609

Articles citing this

Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.97

Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation (2008) 1.62

Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens (2011) 1.54

12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. Am J Physiol Endocrinol Metab (2008) 1.52

Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study. Stroke (2004) 1.42

Fat depots, free fatty acids, and dyslipidemia. Nutrients (2013) 1.30

Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease. Int J Obes (Lond) (2009) 1.30

Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol (2011) 1.30

Variation in internal medicine residency clinic practices: assessing practice environments and quality of care. J Gen Intern Med (2008) 1.26

Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum (2010) 1.21

Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women. Nutr Metab (Lond) (2006) 1.15

Child-to-adult body mass index and height trajectories: a comparison of 2 British birth cohorts. Am J Epidemiol (2008) 1.14

Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad Med J (2005) 1.10

Waist circumference compared with other obesity parameters as determinants of coronary artery disease in essential hypertension: a 6-year follow-up study. Hypertens Res (2016) 1.07

Monocyte chemoattractant protein-1 deficiency protects against visceral fat-induced atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.05

Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis (2011) 1.03

Abdominal obesity: the cholesterol of the 21st century? Can J Cardiol (2008) 1.03

Dietary factors associated with obesity indicators and level of sports participation in Flemish adults: a cross-sectional study. Nutr J (2007) 0.99

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study. Cardiovasc Diabetol (2011) 0.99

The metabolically healthy but obese phenotype in African Americans. J Clin Hypertens (Greenwich) (2011) 0.93

Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system. Br J Pharmacol (2006) 0.93

Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis (2007) 0.92

Fat or fit: what is more important? Diabetes Care (2009) 0.92

ApoE-/- PGC-1α-/- mice display reduced IL-18 levels and do not develop enhanced atherosclerosis. PLoS One (2010) 0.91

Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women. Obes Res Clin Pract (2010) 0.91

Physician diagnosis of overweight status predicts attempted and successful weight loss in patients with cardiovascular disease and central obesity. Am Heart J (2010) 0.88

Anthropometric cutoff values for detecting metabolic abnormalities in Jordanian adults. Diabetes Metab Syndr Obes (2010) 0.86

Metabolic syndrome frequency in inflammatory bowel diseases. Saudi J Gastroenterol (2011) 0.84

Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women. Ann Saudi Med (2009) 0.83

Targeting abdominal obesity in cardiology: can we be effective? Can J Cardiol (2008) 0.82

Advising overweight persons about diet and physical activity in primary health care: Lithuanian health behaviour monitoring study. BMC Public Health (2006) 0.81

Differential vascular dysfunction in response to diets of differing macronutrient composition: a phenomenonological study. Nutr Metab (Lond) (2007) 0.81

Postprandial triglyceride response in normolipidemic, hyperlipidemic and obese subjects - the influence of polydextrose, a non-digestible carbohydrate. Nutr J (2015) 0.80

Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region. BMC Public Health (2009) 0.79

Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. Int J Mol Sci (2013) 0.79

Neck circumference and future cardiovascular events in a high-risk population-A prospective cohort study. Lipids Health Dis (2016) 0.77

Health behaviors and endothelial function. J Behav Med (2007) 0.77

STAT4 contributes to adipose tissue inflammation and atherosclerosis. J Endocrinol (2015) 0.76

K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome. Core Evid (2006) 0.75

The effects of socioeconomic status and short stature on overweight, obesity and the risk of metabolic complications in adults. Colomb Med (Cali) (2013) 0.75

Effect of exercise on anthropometric measures and serum lipids in older individuals: a systematic review and meta-analysis. BMJ Open (2014) 0.75

Effects of dietary milk- and soya-phospholipids on lipid-parameters and other risk indicators for cardiovascular diseases in overweight or obese men - two double-blind, randomised, controlled, clinical trials. J Nutr Sci (2016) 0.75

Evaluation of circulating adipokines and abdominal obesity as predictors of significant myocardial ischemia using gated single-photon emission computed tomography. PLoS One (2014) 0.75

Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus. Diabetol Metab Syndr (2017) 0.75

Ultrasound measurement of pediatric visceral fat thickness: correlations with metabolic and liver profiles. Ann Pediatr Endocrinol Metab (2016) 0.75

Central adiposity is significantly higher in female compared to male in Pakistani type 2 diabetes mellitus patients. Indian J Endocrinol Metab (2015) 0.75

Relationship between body mass index and prognosis of patients presenting with potential acute coronary syndromes. Acad Emerg Med (2013) 0.75

Reappraisal of waist circumference cutoff value according to general obesity. Nutr Metab (Lond) (2016) 0.75

Prevalence of metabolic syndrome and its related factors among North Korean refugees in South Korea: a cross-sectional study. BMJ Open (2016) 0.75

The Relationship between Multiple Health Behaviours and Brachial Artery Reactivity. Int J Hypertens (2012) 0.75

Watch the belly to protect the heart. Eur Heart J (2002) 0.75

Acute myocardial infarction in very young adults: A clinical presentation, risk factors, hospital outcome index, and their angiographic characteristics in North India-AMIYA Study. ARYA Atheroscler (2017) 0.75

Articles by these authors

Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet (1997) 9.18

High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation (1992) 7.11

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20

Preventing non-insulin-dependent diabetes. Diabetes (1995) 6.16

Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet (1994) 6.02

Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse. Soc Sci Med (1997) 5.79

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA (1999) 5.76

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40

Early growth and coronary heart disease in later life: longitudinal study. BMJ (2001) 5.25

Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25

Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ (1999) 5.17

Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. Diabetologia (1999) 5.11

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care (2000) 4.62

The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30

Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23

Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00

Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99

The genetically isolated populations of Finland and sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet (2000) 3.92

Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ (1994) 3.92

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75

Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ (1997) 3.63

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology (2001) 3.56

A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia (1993) 3.35

A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15

The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med (2000) 3.10

Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health (2000) 3.08

The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05

Symptoms of chronic bronchitis and the risk of coronary disease. Lancet (1996) 3.03

Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation (1995) 2.99

Theory and action for health promotion illustrations from the North Karelia Project. Am J Public Health (1982) 2.95

Socioeconomic conditions in childhood and ischaemic heart disease during middle age. BMJ (1990) 2.91

Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol (1994) 2.91

Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ (1995) 2.89

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83

Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80

Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80

Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ (1999) 2.78

Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation (1999) 2.78

Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ (2011) 2.77

Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor study. Int J Epidemiol (1996) 2.73

Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project. Am J Epidemiol (1981) 2.72

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet (2002) 2.65

Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life. Diabetologia (2003) 2.60

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59

Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. BMJ (1995) 2.57

Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet (1978) 2.56

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia (1999) 2.51

Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med (1996) 2.49

Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care (1995) 2.44

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43

Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care (1999) 2.41

Beer binging and mortality: results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study. BMJ (1997) 2.40

Age, body mass index and Type 2 diabetes-associations modified by ethnicity. Diabetologia (2003) 2.37

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J (2002) 2.31

Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. Circulation (1999) 2.29

Body mass index and the risk of Parkinson disease. Neurology (2006) 2.28

Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med Scand Suppl (1988) 2.26

Education and dementia: what lies behind the association? Neurology (2007) 2.26

A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia (1994) 2.25

Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr (2004) 2.25

Decline in cardiovascular mortality in North Karelia and other parts of Finland. Br Med J (Clin Res Ed) (1986) 2.22

Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22

Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. Am J Epidemiol (1982) 2.20

Social connections and mortality from all causes and from cardiovascular disease: prospective evidence from eastern Finland. Am J Epidemiol (1988) 2.20

Telecommunication and international health research. Am J Epidemiol (1988) 2.19

Association between body iron stores and the risk of acute myocardial infarction in men. Circulation (1998) 2.10

Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med (1994) 2.09

Fetal and childhood growth and hypertension in adult life. Hypertension (2000) 2.09

International trends in mortality from stroke, 1968 to 1994. Stroke (2000) 2.09

Cost-effective analysis of candidate genes using htSNPs: a staged approach. Genes Immun (2004) 2.07

Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord (2004) 2.07

Total cholesterol and the risk of Parkinson disease. Neurology (2008) 2.06

Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study. BMJ (1999) 2.06

Socioeconomic status and ischemic stroke: The FINMONICA Stroke Register. Stroke (2001) 2.06

Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06

The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes (Lond) (2005) 2.05

Changes in morbidity and mortality during comprehensive community programme to control cardiovascular diseases during 1972-7 in North Karelia. Br Med J (1979) 2.05

Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: II. Haplotype effects. DiMe Study Group. Childhood Diabetes in Finland. Genet Epidemiol (1995) 2.03

Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation (1996) 2.02

Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke (2000) 2.01

High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes (1990) 2.01